Washington University in Saint Louis

Washington University in St. Louis News & Information >

Gerald L. Andriole Jr.

URL: http://news-info.wustl.edu/sb/page/normal/228.html

Media Assistance:

Diane Duke Williams
Media Coordinator
williamsdia@wustl.edu
(314) 286-0111

Chief of the Division of Urologic Surgery

Expertise: prostate cancer, urologic surgery, penile cancer, bladder cancer, PSA, prostate specific antigen, kidney tumors, kidney cancer

Bio:
Gerald Andriole
Andriole
Download
Clinically, Andriole specializes in prostate cancer, benign prostate hyperplasia, prostatectomy, laparoscopic radical prostatectomy, penile cancer, bladder cancer, PSA, prostate specific antigen, BPH, kidney tumors, kidney cancer.

Education:


Clips:

Showing 2 Clips.
PSA test plus digital exam best at spotting prostate cancer
ABC News online and 4 others

March 25, 2005 -- A combination of both the blood PSA test and the digital rectal exam appears to work best for detecting prostate cancer, according to early results from an ongoing study by WUSTL researchers led by Gerald Andriole.


Prostate drug might cut cancer risk
Reuters (UK) and 1 others

Oct. 18, 2004 -- School of Medicine urologist Gerald Andriole comments on a new drug used to treat an enlarged prostate that apparently also offers men a reduced risk for developing prostate cancer.



Additional Background: An expert on detection and treatment of prostate cancer, Andriole was instrumental in demonstrating the safety of a procedure called hemodilution, which permits radical prostatectomy patients to avoid blood transfusions by donating several units of their own blood minutes before surgery. The blood is then returned at the end of surgery. He is the national principal investigator on several multi-center trials investigating a variety of prostate treatments, including a comparison of herbal versus pharmaceutical treatment and an examination of minimally invasive approaches for detecting prostate cancer. In addition, he leads the St. Louis portion of a National Cancer Institute study known as the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO). This large-scale study will determine whether widespread use of certain cancer-screening tests can save lives.
Related Information


Related Groups: